Teradyne 8-K
PositiveEarningsNew guidance
AI demand drove another revenue record; DRAM strength and a NAND final-test resurgence pushed memory revenue to a record.
Filed 2026-07-29 06:00 ET
- 2.02 Results of Operations
- 9.01 Financial Statements and Exhibits
Summary
Q2 2026 results with Q3 guidance. Revenue reached a second consecutive quarterly record, up 104% Y/Y and above the high end of Q2 guidance; management cited broad market expansion and strong AI-related demand. Record memory revenue reflected continued DRAM strength and a resurgence in NAND final test.
Key Figures
| Metric | Q2 2026 | Q2 2025 | Y/Y |
|---|---|---|---|
| Revenue | $1.33B | $652M | 104% |
| Operating income | $438M | $90.7M | 383% |
| Net income attributable to Teradyne | $375M | $78.4M | 378% |
| Diluted EPS, GAAP | $2.38 | $0.49 | 386% |
| Diluted EPS, non-GAAP | $2.47 | $0.57 | 333% |
| Operating cash flow | $469M | $182M | 158% |
- Segment revenue: Semiconductor Test $1.12B, Product Test $107M and Robotics $100M. Management said all three business groups saw Y/Y market expansion.
- Share repurchases were $68.7M vs $117.4M; weighted-average diluted shares were 157.7M vs 160.1M, down 1.5% Y/Y. Cash and cash equivalents were $349.5M at quarter-end.
Guidance
| Metric | Period | Guidance | Prior | Direction |
|---|---|---|---|---|
| Revenue | Q3 2026 | $1.2B-$1.3B | — | — |
| Net income attributable to Teradyne per diluted share, GAAP | Q3 2026 | $1.79-$2.09 | — | — |
| Net income attributable to Teradyne per diluted share, non-GAAP | Q3 2026 | $1.85-$2.15 | — | — |
Investor Takeaways
- Q3 revenue and diluted EPS vs the guided ranges will test whether robust AI-related demand continues in the near term.
- Management pointed to rising wafer fab equipment investment as a basis for continued growth in 2027 and beyond; its follow-through is a longer-term metric to watch.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3